Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medinotec (MDNC) Research & Development (2022 - 2025)

Historic Research & Development for Medinotec (MDNC) over the last 4 years, with Q4 2025 value amounting to $8326.0.

  • Medinotec's Research & Development fell 8798.04% to $8326.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$151728.0, marking a year-over-year decrease of 99335.85%. This contributed to the annual value of -$91133.0 for FY2025, which is 30773.57% down from last year.
  • Per Medinotec's latest filing, its Research & Development stood at $8326.0 for Q4 2025, which was down 8798.04% from $66235.0 recorded in Q3 2025.
  • In the past 5 years, Medinotec's Research & Development ranged from a high of $69270.0 in Q4 2024 and a low of -$177275.0 during Q1 2025
  • Over the past 4 years, Medinotec's median Research & Development value was $2310.0 (recorded in 2023), while the average stood at -$13789.8.
  • As far as peak fluctuations go, Medinotec's Research & Development tumbled by 56229.0% in 2024, and later soared by 340079.28% in 2025.
  • Medinotec's Research & Development (Quarter) stood at $6405.0 in 2022, then tumbled by 57.41% to $2728.0 in 2023, then surged by 2439.22% to $69270.0 in 2024, then plummeted by 87.98% to $8326.0 in 2025.
  • Its Research & Development was $8326.0 in Q4 2025, compared to $66235.0 in Q3 2025 and -$49014.0 in Q2 2025.